Peroxiredoxin 1 Stimulates Secretion of Proinflammatory Cytokines by Binding to TLR4

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2009 Dec 19

PMID 20018613

Citations 89

Authors

Jonah R Riddell

Xiang-Yang Wang

Hans Minderman

Sandra O Gollnick

Affiliations

Soon will be listed here.

Abstract

Peroxiredoxin 1 (Prx1) is an antioxidant and molecular chaperone that can be secreted from tumor cells. Prx1 is overexpressed in many cancers, and elevation of Prx1 is associated with poor clinical outcome. In the current study, we demonstrate that incubation of Prx1 with thioglycollate-elicited murine macrophages or immature bone marrow-derived dendritic cells resulted in TLR4-dependent secretion of TNF-alpha and IL-6 and dendritic cell maturation. Optimal secretion of cytokines in response to Prx1 was dependent upon serum and required CD14 and MD2. Binding of Prx1 to thioglycollate macrophages occurred within minutes and resulted in TLR4 endocytosis. Prx1 interaction with TLR4 was independent of its peroxidase activity and appeared to be dependent on its chaperone activity and ability to form decamers. Cytokine expression occurred via the TLR-MyD88 signaling pathway, which resulted in nuclear translocation and activation of NF-kappaB. These findings suggest that Prx1 may act as danger signal similar to other TLR4-binding chaperone molecules such as HSP72.

Citing Articles

Unraveling the multifaceted roles of peroxiredoxins in sickle cell anemia: implications in redox and inflammation adaptations.

Romanello K, da Silva J, Torres F, Teixeira K, Domingos I, Arcanjo G Ann Hematol. 2025; .

PMID: 40085210 DOI: 10.1007/s00277-025-06294-1.

Z-Ligustilide: A Potential Therapeutic Agent for Atherosclerosis Complicating Cerebrovascular Disease.

Shen L, Tian Q, Ran Q, Gan Q, Hu Y, Du D Biomolecules. 2025; 14(12.

PMID: 39766330 PMC: 11726876. DOI: 10.3390/biom14121623.

Peroxiredoxin 1-Toll-like receptor 4-p65 axis inhibits receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation.

Park J, Kim S, Jung H, Bae E, Shin M, Park J iScience. 2024; 27(12):111455.

PMID: 39720522 PMC: 11667055. DOI: 10.1016/j.isci.2024.111455.

Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis.

Dalla E, Papanicolaou M, Park M, Barth N, Hou R, Segura-Villalobos D Cell. 2024; 187(23):6631-6648.e20.

PMID: 39378878 PMC: 11568918. DOI: 10.1016/j.cell.2024.09.016.

PRDX1 Interfering Peptide Disrupts Amino Acids 70-90 of PRDX1 to Inhibit the TLR4/NF-κB Signaling Pathway and Attenuate Neuroinflammation and Ischemic Brain Injury.

Ma X, Qi C, Xu X, Li H, Liu C, Wen X Mol Neurobiol. 2024; 61(12):10705-10721.

PMID: 38780721 DOI: 10.1007/s12035-024-04247-9.

References

Lee W, Choi K, Riddell J, Ip C, Ghosh D, Park J . Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2. J Biol Chem. 2007; 282(30):22011-22. DOI: 10.1074/jbc.M610330200. View

Park J, Svetkauskaite D, He Q, Kim J, Strassheim D, Ishizaka A . Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2003; 279(9):7370-7. DOI: 10.1074/jbc.M306793200. View

Kim H, Chae H, Kim Y, Kim Y, Hwangs T, Park E . Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues. Cell Biol Toxicol. 2004; 19(5):285-98. DOI: 10.1023/b:cbto.0000004952.07979.3d. View

Shen J, Person M, Zhu J, Abbruzzese J, Li D . Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 2004; 64(24):9018-26. DOI: 10.1158/0008-5472.CAN-04-3262. View

Williams J, Ireland H . Sensing danger--Hsp72 and HMGB1 as candidate signals. J Leukoc Biol. 2007; 83(3):489-92. DOI: 10.1189/jlb.0607356. View

Higgins S, Lavelle E, McCann C, Keogh B, McNeela E, Byrne P . Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol. 2003; 171(6):3119-27. DOI: 10.4049/jimmunol.171.6.3119. View

El-Omar E, Ng M, Hold G . Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene. 2008; 27(2):244-52. DOI: 10.1038/sj.onc.1210912. View

Chen M, Keng P, Shau H, Wu C, Hu Y, Liao S . Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression. Int J Radiat Oncol Biol Phys. 2006; 64(2):581-91. DOI: 10.1016/j.ijrobp.2005.10.012. View

Chen K, Huang J, Gong W, Iribarren P, Dunlop N, Wang J . Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol. 2007; 7(10):1271-85. DOI: 10.1016/j.intimp.2007.05.016. View

10.

Chen R, Alvero A, Silasi D, Steffensen K, Mor G . Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells. Oncogene. 2008; 27(2):225-33. DOI: 10.1038/sj.onc.1210907. View

11.

Quan C, Cha E, Lee H, Han K, Lee K, Kim W . Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer. J Urol. 2006; 175(4):1512-6. DOI: 10.1016/S0022-5347(05)00659-2. View

12.

Kim H, Park B, Kim J, Kim S, Lee J, Oh S . Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007; 130(5):906-17. DOI: 10.1016/j.cell.2007.08.002. View

13.

Lin W, Karin M . A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007; 117(5):1175-83. PMC: 1857251. DOI: 10.1172/JCI31537. View

14.

Hunter-Lavin C, Davies E, Bacelar M, Marshall M, Andrew S, Williams J . Hsp70 release from peripheral blood mononuclear cells. Biochem Biophys Res Commun. 2004; 324(2):511-7. DOI: 10.1016/j.bbrc.2004.09.075. View

15.

Gollnick S, Liu X, Owczarczak B, Musser D, Henderson B . Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 1997; 57(18):3904-9. View

16.

Qi Y, Chiu J, Wang L, Kwong D, He Q . Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics. 2005; 5(11):2960-71. DOI: 10.1002/pmic.200401175. View

17.

Furuta T, Imajo-Ohmi S, Fukuda H, Kano S, Miyake K, Watanabe N . Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin. Eur J Immunol. 2008; 38(5):1341-50. DOI: 10.1002/eji.200738059. View

18.

Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S . Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992; 176(6):1693-702. PMC: 2119469. DOI: 10.1084/jem.176.6.1693. View

19.

Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R . The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev. 2007; 220:47-59. DOI: 10.1111/j.1600-065X.2007.00573.x. View

20.

Binder R, Harris M, Menoret A, Srivastava P . Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells. J Immunol. 2000; 165(5):2582-7. DOI: 10.4049/jimmunol.165.5.2582. View